Cargando…
Low serum level of apolipoprotein A1 may predict the severity of COVID‐19: A retrospective study
BACKGROUND: Dyslipidemia has been observed in patients with coronavirus disease 2019 (COVID‐19). This study aimed to investigate blood lipid profiles in patients with COVID‐19 and to explore their predictive values for COVID‐19 severity. METHODS: A total of 142 consecutive patients with COVID‐19 wer...
Autores principales: | Zhu, Zhe, Yang, Yayun, Fan, Lingyan, Ye, Shuyuan, Lou, Kehong, Hua, Xin, Huang, Zuoan, Shi, Qiaoyun, Gao, Guosheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373354/ https://www.ncbi.nlm.nih.gov/pubmed/34260764 http://dx.doi.org/10.1002/jcla.23911 |
Ejemplares similares
-
The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020) -
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020) -
Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case
por: Gao, Guosheng, et al.
Publicado: (2020) -
Serum apolipoprotein E may be a novel biomarker of migraine
por: Yuasa, Naoki, et al.
Publicado: (2018) -
Serum apolipoprotein B-to-apolipoprotein A1 ratio is independently associated with disease severity in patients with acute pancreatitis
por: Wu, Jiayuan, et al.
Publicado: (2019)